| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/04/2009 | WO2009051451A3 Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same |
| 06/04/2009 | WO2009050555A3 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 06/04/2009 | WO2009050217A3 Improved pharmaceutical dry powder compositions for inhalation |
| 06/04/2009 | WO2009046446A3 Dendrimers for sustained release of compounds |
| 06/04/2009 | WO2009029958A3 Implantable delivery device |
| 06/04/2009 | WO2009029087A3 Superporous hydrogels |
| 06/04/2009 | WO2009024590A3 Antifungal composition |
| 06/04/2009 | WO2009013115A3 Vesicles comprising a transmembrane transport trigger system |
| 06/04/2009 | WO2009007785A3 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 06/04/2009 | WO2009007687A3 An inhalable medicament |
| 06/04/2009 | WO2008155589A3 Biocide capsules, preparation comprising them and sanitary pad comprising the preparation |
| 06/04/2009 | WO2008147245A3 Controlled release proxodolol pharmaceutical composition |
| 06/04/2009 | WO2008142569A3 Topical compositions containing magaldrate |
| 06/04/2009 | WO2008138459A3 Aqueous pharmaceutical preparation |
| 06/04/2009 | WO2008137054A3 Composition for transmucosal delivery of polypeptides |
| 06/04/2009 | WO2008134734A3 Encapsulated contrast agents |
| 06/04/2009 | WO2008127794A3 Granular material for dosage forms |
| 06/04/2009 | WO2008115811A3 Transdermal delivery form disposal systems and methods |
| 06/04/2009 | WO2008094693A4 Compositions for aerosolization of highly conductive solutions |
| 06/04/2009 | WO2007111636A3 Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
| 06/04/2009 | WO2007061878A3 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| 06/04/2009 | WO2007018585A3 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition |
| 06/04/2009 | WO2006099386A3 Synthesis and use of colloidal iii-v nanoparticles |
| 06/04/2009 | US20090143747 Coiled wire for the controlled release of drugs to the eye |
| 06/04/2009 | US20090143724 Microprojection Array Immunization Patch and Method |
| 06/04/2009 | US20090143583 Transfection reagents |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143479 Pharmaceutical compositions comprising terbinafine |
| 06/04/2009 | US20090143477 Antimicrobial Nanoemulsion Compositions and Methods |
| 06/04/2009 | US20090143476 Antimicrobial Nanoemulsion Compositions and Methods |
| 06/04/2009 | US20090143475 Bronchodilating beta-agonist compositions and methods |
| 06/04/2009 | US20090143459 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/04/2009 | US20090143387 Sustained-release tablet composition |
| 06/04/2009 | US20090142850 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 06/04/2009 | US20090142408 Telomerase delivery by biodegradable Nanoparticle |
| 06/04/2009 | US20090142407 Solid peptide preparations for inhalation and their preparation |
| 06/04/2009 | US20090142405 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/04/2009 | US20090142404 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 06/04/2009 | US20090142403 Organ regeneration device |
| 06/04/2009 | US20090142402 Microparticles, microparticle dispersion and method and apparatus for producing the same |
| 06/04/2009 | US20090142401 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
| 06/04/2009 | US20090142400 Analgesic coated medical product |
| 06/04/2009 | US20090142399 Dispersant agent for sustained-release preparations |
| 06/04/2009 | US20090142398 Novel pharmaceutical compositions comprising a disintegration matrix |
| 06/04/2009 | US20090142397 Reduction of dermal scarring |
| 06/04/2009 | US20090142396 Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| 06/04/2009 | US20090142395 Deferasirox pharmaceutical compositions |
| 06/04/2009 | US20090142394 Gastric Antacid |
| 06/04/2009 | US20090142393 Stable Compositions of Famotidine and Ibuprofen |
| 06/04/2009 | US20090142392 Composition Comprising a NSAID and Paracetamol |
| 06/04/2009 | US20090142391 Conjugated RNAi Therapeutics |
| 06/04/2009 | US20090142390 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
| 06/04/2009 | US20090142389 Hydrogel sheet and production method thereof |
| 06/04/2009 | US20090142388 Patch preparation |
| 06/04/2009 | US20090142384 Viscoelastic material |
| 06/04/2009 | US20090142383 O/w emulsion cosmetic composition |
| 06/04/2009 | US20090142379 Coated Products Containing Hydrogenated Indigestible Starch Syrup as a Binding Agent |
| 06/04/2009 | US20090142378 Controlled release dosage forms |
| 06/04/2009 | US20090142377 Immunogenic compositions |
| 06/04/2009 | US20090142325 Compositions and methods for treating tumour spreading |
| 06/04/2009 | US20090142324 Oil-in-water type emulsion containing coenzyme q10 and process for producing the same |
| 06/04/2009 | US20090142321 Opthalmic composition |
| 06/04/2009 | US20090142280 Protective skin care peptides |
| 06/04/2009 | US20090142278 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
| 06/04/2009 | US20090142277 Treatment of active infections and related compositions |
| 06/04/2009 | US20090142267 Fusogenic properties of saposin c and related proteins and peptides for application to tansmembrane drug delivery systems |
| 06/04/2009 | US20090140207 Microencapsulated particles and process for manufacturing same |
| 06/04/2009 | DE19549852B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/04/2009 | DE10315878B4 Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung The transdermal administration of fesoterodine and use |
| 06/04/2009 | DE102007058112A1 Pulverinhalator mit Wirkstofftablette Powder inhaler with active tablet |
| 06/04/2009 | CA2706517A1 Nanoemulsions |
| 06/04/2009 | CA2706379A1 A method for producing adapalene gels |
| 06/04/2009 | CA2706014A1 Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals |
| 06/04/2009 | CA2704826A1 Method for producing granulated preparation |
| 06/04/2009 | CA2703913A1 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
| 06/04/2009 | CA2692765A1 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065075A1 Water-in-oil emulsion composition and cosmetic emulsion comprising the same |
| 06/03/2009 | EP2065063A1 Needleless injection device |
| 06/03/2009 | EP2065056A1 Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same |
| 06/03/2009 | EP2065055A1 Holt-melt extrudable pharmaceutical formulation |
| 06/03/2009 | EP2065045A1 Antioxidant for preventing and treating diseases caused by oxidative stress |
| 06/03/2009 | EP2065043A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 06/03/2009 | EP2065042A2 Antiparasitic composition containing an organic amine salt of closantel |
| 06/03/2009 | EP2065036A1 Vitamin supplement |
| 06/03/2009 | EP2065035A1 Pharmaceutical formulations containing irbesartan |
| 06/03/2009 | EP2065034A2 Enteric-coated glucosinolates and beta-thioglucosidases |
| 06/03/2009 | EP2065033A1 Microemulsions of cannabinoid receptor binding compounds |
| 06/03/2009 | EP2065032A1 A method for producing adapalene gels |
| 06/03/2009 | EP2064252A2 Process for the preparation of sevelamer hydrochloride and formulation thereof |
| 06/03/2009 | EP2063970A1 Preparation of fine particles |
| 06/03/2009 | EP2063969A1 Process and device for the precipitation of an organic compound |
| 06/03/2009 | EP2063953A2 Device for the controlled release of a predefined quantity of a substance |
| 06/03/2009 | EP2063876A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 06/03/2009 | EP2063875A2 Combination pharmaceutical compositions |
| 06/03/2009 | EP2063874A1 Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby |
| 06/03/2009 | EP2063873A2 Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
| 06/03/2009 | EP2063872A1 Controlled release oral dosage formulations comprising a core and one or more barrier layers |
| 06/03/2009 | EP2063871A1 Controlled release solid oral dosage formulations comprising nisoldipine |
| 06/03/2009 | EP2063870A2 Oral modified release formulations |